In a strategic shift, Lord’s Mark Industries is set to launch an extensive healthcare expansion alongside a business demerger. This initiative will prioritize advancements in diagnostics, oncology, and cutting-edge medical devices, bringing CAR-T cell therapy and specialized oncology hospitals to a wider Indian demographic. The company’s international vision includes launching subsidiaries in the UK and Switzerland, aiming to bolster its diagnostic capabilities and strengthen its healthcare service value chain.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.